Welcome to Chasing Compliance, the GLOBAL regulatory podcast, where we discuss all aspects of medical device and pharmaceutical regulatory and clinical strategy – from bench to bedside. Today we are chatting with Emily Stephens, the founder and CEO of GLOBAL. Emily worked in the medical device and biologics industries for thirteen years before launching GLOBAL in early 2014. After years of 60-hour work weeks for CROs that were notorious for burning out workers, she developed an autoimmune disease that would forever change her vision of the medical writing industry. Life was too short for burnout. She wondered: What would happen if there was a company that treated workers with respect, loyalty, and deeply advocated for their work/life balance? ‍Out of this question GLOBAL was born and the outcome has been spectacular: We attract the best, who then perform at their best, because this is a place where we fiercely take care of each other. Thank you for being here, Em! On this episode, we are exploring 2026 – what are we looking forward to, what are we looking out for, and what opportunities exist. Let’s dive in!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related